Cost-Utility Analysis and Drug Pricing of Icodec vs Degludec for Patients With Type 2 Diabetes Receiving Basal Insulin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cost-utility analysis and drug pricing of once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes patients treated with basal insulin in China
Diabetes Obes Metab 2024 Sep 30;[EPub Ahead of Print], S Hu, S Wang, S Gu, C Qi, C Shi, G FanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.